Integrated Advisors Network’s Charles River Laboratories CRL Stock Holding History

Integrated Advisors Network’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,491	Closed	-$319K	–	652
2022 Q2	$319K	Sell	1,491 -209	-12%	-$51.1K	0.02%	512
2022 Q1	$483K	Sell	1,700 -114	-6%	-$35.2K	0.03%	447
2021 Q4	$683K	Sell	1,814 -153	-8%	-$59.4K	0.04%	357
2021 Q3	$812K	Buy	1,967 +34	+2%	+$14.1K	0.05%	308
2021 Q2	$715K	Hold	1,933	–	–	0.05%	290
2021 Q1	$560K	Buy	1,933 +116	+6%	+$32.2K	0.05%	313
2020 Q4	$454K	Buy	1,817 +131	+8%	+$31.2K	0.05%	297
2020 Q3	$382K	Buy	1,686 +121	+8%	+$25.1K	0.05%	302
2020 Q2	$273K	Buy	+1,565	New	+$250K	0.03%	365

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Integrated Advisors Network's CRL Position: Q3 2022 in Review

Integrated Advisors Network sold out of Charles River Laboratories (CRL) in Q3 2022, closing a stake of 1,491 shares — an estimated $319K sold.

Integrated Advisors Network first reported a position in CRL in Q2 2020 and held it in 9 quarters. The position peaked at $812K in Q3 2021. 583 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

Integrated Advisors Network reported no remaining Charles River Laboratories position as of Q3 2022 after selling out during the quarter.
Integrated Advisors Network sold 1,491 Charles River Laboratories shares in Q3 2022, an estimated $319K.
Integrated Advisors Network first reported a position in Charles River Laboratories in Q2 2020 and held it in 9 quarters.
Integrated Advisors Network's Charles River Laboratories position peaked at $812K in Q3 2021.
583 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on Integrated Advisors Network's 13F filing for Q3 2022, filed 8 Nov 2022.